Baxter International Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
071813109
SEDOL
2085102
CIK
0000010456
www.baxter.com
LEI:
©
FIGI: BBG000BCVJ77
BAX
Baxter International Inc.
GICS: 35101010 · Sektor: Healthcare · Sub-Sektor: Medical - Instruments & Supplies
NAME
Baxter International Inc.
ISIN
US0718131099
TICKER
BAX
MIC
XNYS
REUTERS
BAX.N
BLOOMBERG
BAX US
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
GIF DE 728x90
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
TradingView ActivTrader MT4 MT5
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 09.09.2024       Baxter International
US0718131099

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. Mr. Craig will serve on Baxter’s Audit Committee. His appointment is effective today and brings the total number of direc...
weiterlesen
Baxter International
Research & Analysen Termsheet Terminal
Permalink
Mi., 28.08.2024       Baxter International
US0718131099

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be availabl...
weiterlesen
Baxter International
Research & Analysen Termsheet Terminal
Permalink
Di., 13.08.2024       Baxter International
US0718131099

Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion. This press release features multimedia. View the full rel...
weiterlesen
Baxter International
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements